Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study–Rationale and design of the PACMAN-AMI trial

Christian Zanchin, Konstantinos C. Koskinas, Yasushi Ueki, Sylvain Losdat, Jonas Häner, Sarah Bär, Tatsuhiko Otsuka, Andrea Inderkum, Maria Radu Juul Jensen, Jacob Lønborg, Gregor Fahrni, Anna S. Ondracek, Joost Daemen, Robert‐Jan van Geuns, Juan F. Iglesias, Christian M. Matter, David Spirk, Peter Jüni, François Mach, Dik Heg, Thomas Engstrøm, Iréne Lang, Stephan Windecker, Lorenz Räber